Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1999-01-26 to 1999-02-10
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted in compliance with EEC-Guideline B1 and OECD Guidelines for testing chemicals 401 according to the good laboratory practice regulations annex of paragraph 19a, section 1 of the chemical law of July, 25, 1994.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Version / remarks:
Standard acute method
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Details on test material:
-Name of test material (as cited in study report): Reaktiv-Orange DYPR934

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST SYSTEM
Species Sprague Dawley rat
Strain HSD: Sprague Dawley SD
Origin HARLAN WINKELMANN
(SPF breeding colony)
Body weight at start of the experiment
Male animals Mean = 206g (=100%)
S =± 6.1 g
Min= 198 g (-3.9%)
Max = 212 g (+2.9%)
n = 5
Female animals Mean = 179 g (=100%)
S =± 5.4 g
Min= 172 g (-3.9%)
Max = 184 g (+2.8%)
n = 5
Age at the start of the study: 6-10 weeks
Randomization Randomization schemes: 98.0941, 98.0704
Animal maintenance: in fully air-conditioned rooms in macrolon cages (type 4) on soft wood granulate in groups of 5 animals
Room temperature: 22±3°C
Relative humidity: 50± 20%
Lighting time: 12 hours daily
Acclimatization: at least seven days
Food: ssniff® R/M-H (V 1534), ad libitum
Withdrawal of food: from about 16 hours before to 3-4 hours after treatment
Water: tap water in plastic bottles, ad libitum
Animal identification: fur marking with KmnO4


Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: Deionized water
Details on oral exposure:

VEHICLE
- Concentration in vehicle and amount of vehicle: The animals received the compound as a 20 % solution in deionized water, the administration volume being 10 mL/kg body weight
-Oral gavage to fasted animals:
2000 mg/kg bodyweight (base on a dose range finding study)


Doses:
2000 mg/kg solution in deionized water (10 mL/kg) bw.
No. of animals per sex per dose:
5 males and 5 females
Control animals:
no
Details on study design:
Duration of observation period following administration: 14 days (The observation period following treatment lasted for 14 days)
Frequency of observations and weighing: Symptoms recorded twice every day (in the morning and in the afternoon) on weekends and public holidays, only once. During this time the animals were weighed weekly. At the end of the observation period the animals

Necropsy of survivors performed: yes
Clinicals observations: the following clinical signs were observed after the administration of Reaktiv-Orange DYPR 934:
Squatting posture, stilted gate, irregular respiration, diarrhea and orange discolored feces.
Body weight: development of body weight was not impaired
Lethality: no death occurred during the whole study

Results and discussion

Preliminary study:
No lethality occurred after application of 2000 mg/kg body weight:
Besides unspecific symptoms:
Impairments of mobility and respiration. Additionally diarrhea and orange discolored feces were observed.
Clinical signs: squatting posture, stilted gait, irregular respiration, diarrhea and orange discolored feces.
At day two of the study the irritations were disappeared.

Development of body weight was not impaired
Autopsy findings: no macroscopically visible changes

No symptoms were observed after administration of 500 mg/kg body weight
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
Male: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Female: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Clinical signs:
other: No deaths occurred during the whole study. The following clinical signs were observed after the administration of the test substance: squatting posture, stilted gait, irregular respiration, diarrhea and orange discolored feces. At day two of the study t
Gross pathology:
INDIVIDUAL GROSS PATHOLOGY OBSERVATIONS
Group I: Dose: 2000 mg/kg body weight Sex: female
Animal number Mode of Death Death
Day (Week) Observation(s)
6 SCHEDULED KILL: FINAL 15 (3) No visible Lesions
7 SCHEDULED KILL: FINAL 15 (3) No visible Lesions
8 SCHEDULED KILL: FINAL 15 (3) No visible Lesions
9 SCHEDULED KILL: FINAL 15 (3) No visible Lesions
10 SCHEDULED KILL: FINAL 15 (3) No visible Lesions



The animals killed at the end of the observation period showed no macroscopically visible changes.
Other findings:
- Other observations: No deaths occurred during the whole study.

Any other information on results incl. tables

Dose Range finding study

Test substance: Reaktiv-Orange DYPR 934

Vehicle: dionized water

Concentration: 20%

Dose

Mg/kg Body weight

Sex

(m/f)

Date of administration

Body weight (g)

Days after administration

0      7            14

               Lethality

 

 

Time                      bw

P.a                            [g]                    

2000

m

f

1999-01-26

214   268      295

-

-

1999-01-26

170   220      220

-

-

1000

m

f

1999-01-26

198    243     263

-

-

1000

1999-01-26

158     195    203

-

-

500

m

f

1999-01-26

210     267    292

-

-

500

1999-01-26

172     202    217

-

-

Comprehensive description of clinicals signs:

No deaths occurred during the whole study.

The following clinical signs were observed after the administration of the test substance in the 1000 and 2000 mg/kg bw. group: squatting posture, stilted gait, diarrhea and orange discolored feces. At day two of the study the irritations were disappeared. Development of body weight was not impaired.

No symptoms was observed after administration of 500 mg/kg body weight.

Comprehensive description of the macroscopic findings:

The animals killed at the end of the observation showed no macroscopically visible changes.

No lethality occurred after application of 2000 mg/kg body weight.

 

                                                      Table I: Bodyweights-Individual Bodyweights

Study: 99. 0012-Acute Oral Toxicity with Reaktiv-Orange DYPR 934 in Rats

 

Table 1: Bodyweights: Individual Bodyweights

 

                                                       Day numbers relative to Start Date

 

Group

Sex

Animal Number

1

6

15

 

1m

1

212

265*

287

 

 

2

206

261*

269

 

 

3

211

265*

303

 

 

4

201

260*

287

 

 

5

198

258*

296

 

 

Mean

205.6

261.8

292.4

 

 

S.D.

6.1

3.1

7.0

 

 

N

5

5

5

 

1 f

6

184

208

216

 

 

7

181

207

215

 

 

8

172

197

207

 

 

9

183

210

216

 

 

10

174

203

210

 

 

Mean

178.6

205.0

212.8

 

 

S.D.

5.4

5.1

4.1

 

 

N

5

5

5

 

*= result to left has an associated comment or marker

Nominal Dose: Group 1-2000 mg/kg bodyweight

 

Comments and Markers

 

Measurement

Group

Sex

Animal number

Day Number

Type

Marker Comment

Bodyweights

1 m

1

8

Out of range

 

2

8

Out of range

 

3

8

Out of range

 

4

8

Out of range

 

5

8

Out of range

Marker= implies value excluded from means

                                                       Day numbers relative to Start Date

                                   Table 2: Bodyweights Gains- Individual Bodyweight Gains

 

Group

Sex

Animal Number

From

 

To

1

 

8

8

 

15

 

1m

1

 

53*

22*

 

 

2

 

55*

28*

 

 

3

 

54*

38*

 

 

4

 

59*

27*

 

 

5

 

50*

38*

 

 

 

Mean

56.2

30.6

 

 

 

S.D.

3.1

7.1

 

 

 

N

5

5

                                   *= result to left has an associated comment or marker

                                         Nominal Dose: Group 1-2000 mg/kg bodyweight

 

Group

Sex

Animal Number

From

 

To

1

 

8

8

 

15

 

1f

6

 

24

8

 

 

7

 

26

8

 

 

8

 

25

10

 

 

9

 

27

6

 

 

10

 

29

7

 

 

 

Mean

26.2

7.8

 

 

 

S.D.

1.9

1.5

 

 

 

N

5

5

 

 

Clinical Observations-

Table 3: Clinical signs by Animal

                                                       Day numbers relative to Start Date

Group Sex

Animal Number

Clinical Sign

I

0-10 min

Post dos

I

10-30 min

Post dos

I

30-60 min

Post dos

 

1-2 hrs

Post dos

I

2-4 hrs

Post dos

I

4-8 hrs

Pos dos

1 m

1

No Abnormalities Detected

X

X

-

-

-

-

 

 

Gait stilted

-

-

X

X

X

X

 

Squatting posture

-

-

X

X

X

X

 

Diarrhea

-

-

-

-

X

X

 

Feces discolored

-

-

-

o

o

o

 

Irregular respiration

-

-

-

-

-

-

 

2

 

No Abnormalities Detected

X

X

X

-

-

-

 

Gait stilted

-

-

-

X

X

-

 

Squatting posture

-

-

-

X

X

-

 

Feces discolored

-

-

-

-

o

o

 

Irregular respiration

-

-

-

-

X

-

 

 

 

 

 

 

 

 

 

3

 

No Abnormalities Detected

X

X

-

-

-

-

 

Gait stilted

-

-

X

X

X

X

 

Squatting posture

-

-

X

X

X

X

 

Feces discolored

-

-

-

-

o

o

 

Irregular respiration

-

-

-

-

X

X

 

 

 

 

 

 

 

 

 

4

 

No Abnormalities Detected

X

X

-

-

-

-

 

Gait stilted

-

-

X

X

X

-

 

Squatting posture

-

-

X

X

X

-

 

Feces discolored

-

-

-

-

0

0

5

No Abnormalities Detected

X

X

-

-

-

-

 

Gait stilted

-

-

X

X

X

X

 

 

Squatting posture

-

-

X

X

X

X

 

Feces discolored

-

-

-

o

o

0

 

 

X

 

 

 

 

 

 

Diarrhea

X

X

X

X

X

X

 

 

X

X

X

X

X

X

 

Irregular respiration

X

X

X

X

X

X

 1f

6

No Abnormalities Detected

X

X

-

-

-

-

 

Gait stilted

-

-

X

X

X

X

 

Squatting posture

-

-

X

X

X

X

 

Diarrhea

-

-

-

X

X

X

 

Feces discolored

-

-

-

o

o

o

 

Irregular respiration

-

-

-

-

X

X

 

7

No Abnormalities Detected

X

-

-

 

-

-

 

Gait stilted

-

X

X

X

X

X

 

Squatting posture

-

X

X

X

X

X

 

Diarrhea

-

-

X

X

X

X

 

Feces discolored

-

-

o

o

o

o

 

 

 

 

 

 

 

 

 

8

No Abnormalities Detected

X

-

-

-

-

-

 

Gait stilted

-

X

X

X

X

X

 

Squatting posture

-

X

X

X

X

X

 

Diarrhea

-

-

X

X

X

X

 

Feces discolored

-

-

o

o

o

o

 

Irregular respiration

-

-

-

-

X

X

 

9

No Abnormalities Detected

X

X

-

-

-

-

 

Gait stilted

-

-

X

X

X

X

 

Squatting posture

-

-

X

X

X

X

 

Diarrhea

-

-

-

X

X

X

 

Feces discolored

-

-

-

o

o

o

 

10

No Abnormalities Detected

X

-

-

-

-

-

 

Gait stilted

-

X

X

X

X

X

 

Squatting posture

-

X

X

X

X

X

 

Diarrhea

-

-

X

X

X

X

 

Feces discolored

-

-

o

o

o

o

 

Irregular respiration

-

-

-

-

X

-

X= Present

O= orange

Nominal Dose: Group I -2000mg/ kg bodyweight 

-result to left has an associated comment or marker

 

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Based on results obtained in this study the median lethal dose value (LD50) of Reaktiv Orange DYPR 934 for the male and female rat is greater than 2000 mg/kg body weight.
Executive summary:

In an acute toxicity oral study (conducted in accordance with the OECD Guideline), Reaktiv-Orange DYPR 934 was administrated by gavage to 5 male and 5 female of Sprague Dawley rats.

The observation period following treatment lasted for 14 days. Symptoms were recorded twice every day (in the morning and in the afternoon) on weekends and public holidays, only once. During this time the animals were weighed weekly. At the end of the observation period the animals were killed by carbone dioxide asphyxiation, dissected and examined for macroscopically visible changes.

The acute oral toxicity testing of Reaktiv-Orange DYPR 934 in the rat yielded a median lethal dose (LD50) above 2000 mg/kg body weight in both male of female animals. No lethality occurred after application of 2000 mg/kg body weight. Besides unspecific symptoms the animals showed impairments of mobility and respiration. Additionally the diarrhea and orange discolored faces were observed. At day two of the study the irritations were disappeared. Development of body weight was not impaired. The animals killed at the end of the observation period showed no macroscopically visible changes.

Results Synopsis and test report:

Species

Strain

Origin

Sex of animals dosed

Tabulation of response data by dose level

LD50 Value

Findings

Sprague Dawley rats

 

HSD: Sprague Dawley SD

Harlan Winkelmann

Gartenstr. 27, 33178 Borchen

(SPF breeding colony)

Male and female

No animals died during the test.

>2000 mg/kg body weight

The animals killed at the end of the observation period showed no macroscopically visible changes.